Publications
Detailed Information
Mitochondrial dysfunction and metabolic syndrome-looking for environmental factors
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Lee, Hong Kyu | - |
dc.contributor.author | Cho, Young Min | - |
dc.contributor.author | Kwak, Soo Heon | - |
dc.contributor.author | Lim, Soo | - |
dc.contributor.author | Shim, Eun Bo | - |
dc.contributor.author | Park, Kyong Soo | - |
dc.date.accessioned | 2012-05-30T00:51:20Z | - |
dc.date.available | 2012-05-30T00:51:20Z | - |
dc.date.issued | 2010-03 | - |
dc.identifier.citation | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS; Vol.1800 3; 282-289 | ko_KR |
dc.identifier.issn | 0304-4165 | - |
dc.identifier.uri | https://hdl.handle.net/10371/76599 | - |
dc.description.abstract | The centerpiece of the pathophysiologic mechanism of metabolic syndrome is insulin resistance. Recently, it is becoming evident that mitochondrial dysfunction is closely related to insulin resistance and metabolic syndrome. The underlying mechanism of mitochondrial dysfunction is very complex, which includes genetic factors from both nuclear and mitochondrial genome and numerous environmental factors. Several mitochondrial DNA polymorphisms are associated with the components of metabolic syndrome. Numerous chemicals and drugs may cause mitochondrial dysfunction and insulin resistance. Notably, it was recently reported that serum levels of several mitochondrial toxins, such as persistent organic pollutants are associated with metabolic syndrome, which necessitates further investigation to reveal its precise mechanism. Given that the health impact of metabolic syndrome is tremendous, it is necessary to develop therapeutic modalities to correct mitochondrial dysfunction or at least to halt its aggravation. In this regard, exercise can improve both mitochondrial function and insulin sensitivity, and some pharmaceutical agents were reported to improve mitochondrial function. However, further studies are warranted to find more effective therapeutic strategies to treat mitochondrial dysfunction. By doing so, we can also shed light on the path of research for other diseases related to mitochondrial dysfunction. (C) 2009 Elsevier B.V. All rights reserved. | ko_KR |
dc.language.iso | en | ko_KR |
dc.publisher | ELSEVIER SCIENCE BV | ko_KR |
dc.subject | Insulin resistance | ko_KR |
dc.subject | Scaling law | ko_KR |
dc.subject | Type 2 diabetes mellitus | ko_KR |
dc.subject | Persistent organic pollutant | ko_KR |
dc.subject | Metabolic syndrome | ko_KR |
dc.subject | Mitochondrial dysfunction | ko_KR |
dc.title | Mitochondrial dysfunction and metabolic syndrome-looking for environmental factors | ko_KR |
dc.type | Article | ko_KR |
dc.contributor.AlternativeAuthor | 이홍규 | - |
dc.contributor.AlternativeAuthor | 조영민 | - |
dc.contributor.AlternativeAuthor | 곽수현 | - |
dc.contributor.AlternativeAuthor | 임수 | - |
dc.contributor.AlternativeAuthor | 박경수 | - |
dc.contributor.AlternativeAuthor | 심은보 | - |
dc.identifier.doi | 10.1016/j.bbagen.2009.11.010 | - |
dc.citation.journaltitle | BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS | - |
dc.description.citedreference | Gerschenson M, 2009, J ANTIMICROB CHEMOTH, V63, P1244, DOI 10.1093/jac/dkp100 | - |
dc.description.citedreference | Lim S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005186 | - |
dc.description.citedreference | Weng SW, 2009, DIABETES RES CLIN PR, V83, P94, DOI 10.1016/j.diabres.2008.10.002 | - |
dc.description.citedreference | Heijmans BT, 2008, P NATL ACAD SCI USA, V105, P17046, DOI 10.1073/pnas.0806560105 | - |
dc.description.citedreference | O`Rahilly S, 2008, DIABETES, V57, P2905, DOI 10.2337/db08-0210 | - |
dc.description.citedreference | Lim JS, 2008, DIABETES CARE, V31, P1802, DOI 10.2337/dc08-0850 | - |
dc.description.citedreference | Tentolouris N, 2008, NEUROMOL MED, V10, P169, DOI 10.1007/s12017-008-8022-5 | - |
dc.description.citedreference | Singer GM, 2008, J CLIN HYPERTENS, V10, P567 | - |
dc.description.citedreference | Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5 | - |
dc.description.citedreference | Park KS, 2008, DIABETOLOGIA, V51, P602, DOI 10.1007/s00125-008-0933-z | - |
dc.description.citedreference | Wagner BK, 2008, NAT BIOTECHNOL, V26, P343 | - |
dc.description.citedreference | Lee DH, 2008, DIABETOLOGIA, V51, P402, DOI 10.1007/s00125-007-0896-5 | - |
dc.description.citedreference | Biswas G, 2008, P NATL ACAD SCI USA, V105, P186, DOI 10.1073/pnas.0706183104 | - |
dc.description.citedreference | JAMES YW, 2008, DRUG INDUCED MITOCHO | - |
dc.description.citedreference | Ling C, 2007, J CLIN INVEST, V117, P3427, DOI 10.1172/JC130938 | - |
dc.description.citedreference | Pravenec M, 2007, GENOME RES, V17, P1319, DOI 10.1101/gr.6548207 | - |
dc.description.citedreference | Das S, 2007, J CLIN ENDOCR METAB, V92, P3219, DOI 10.1210/jc.2007-0702 | - |
dc.description.citedreference | Singh R, 2007, DIABETIC MED, V24, P784, DOI 10.1111/j.1464-5491.2007.02164.x | - |
dc.description.citedreference | Nakagawa Y, 2007, XENOBIOTICA, V37, P693, DOI 10.1080/00498250701397697 | - |
dc.description.citedreference | Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190 | - |
dc.description.citedreference | Fuku N, 2007, AM J HUM GENET, V80, P407, DOI 10.1086/512202 | - |
dc.description.citedreference | Major GC, 2007, INT J OBESITY, V31, P204, DOI 10.1038/sj.ijo.0803523 | - |
dc.description.citedreference | Shertzer HG, 2006, TOXICOL APPL PHARM, V217, P363, DOI 10.1016/j.taap.2006.09.014 | - |
dc.description.citedreference | Lee DH, 2006, J EPIDEMIOL COMMUN H, V60, P1006, DOI 10.1136/jech.2006.053389 | - |
dc.description.citedreference | Schuh RA, 2005, TOXICOL SCI, V88, P495, DOI 10.1093/toxsci/kfi334 | - |
dc.description.citedreference | Chinnery PF, 2005, LANCET, V366, P1650, DOI 10.1016/S0140-6736(05)67492-2 | - |
dc.description.citedreference | Mohlke KL, 2005, HUM GENET, V118, P245, DOI 10.1007/s00439-005-0046-4 | - |
dc.description.citedreference | Cho YM, 2005, DIABETOLOGIA, V48, P2033, DOI 10.1007/s00125-005-1855-7 | - |
dc.description.citedreference | t Hart LM, 2005, DIABETES, V54, P1892 | - |
dc.description.citedreference | Park SY, 2005, J BIOL CHEM, V280, P9855, DOI 10.1074/jbc.M409399200 | - |
dc.description.citedreference | Jandacek RJ, 2005, AM J PHYSIOL-GASTR L, V288, pG292, DOI 10.1152/ajpgi.00285.2004 | - |
dc.description.citedreference | Lee HK, 2005, ANN NY ACAD SCI, V1042, P1, DOI 10.1196/annals.1338.001 | - |
dc.description.citedreference | Chun PW, 2005, PHYS SCRIPTA, VT118, P219 | - |
dc.description.citedreference | Dulloo AG, 2004, PHYSIOL BEHAV, V83, P587, DOI 10.1016/j.physbeh.2004.07.028 | - |
dc.description.citedreference | Ling C, 2004, J CLIN INVEST, V114, P1518, DOI 10.1172/JCI200421889 | - |
dc.description.citedreference | Lee DH, 2004, J CLIN ENDOCR METAB, V89, P5410, DOI 10.1210/jc.2004-0505 | - |
dc.description.citedreference | Gluckman PD, 2004, SCIENCE, V305, P1733 | - |
dc.description.citedreference | Tremblay A, 2004, INT J OBESITY, V28, P936, DOI 10.1038/sj.ijo.0802527 | - |
dc.description.citedreference | Lee DH, 2004, AM J CLIN NUTR, V79, P600 | - |
dc.description.citedreference | Petersen KF, 2004, NEW ENGL J MED, V350, P664 | - |
dc.description.citedreference | Lewis W, 2003, NAT REV DRUG DISCOV, V2, P812, DOI 10.1038/nrd1201 | - |
dc.description.citedreference | Park KS, 2003, J NUTR, V133, P3085 | - |
dc.description.citedreference | Ristow M, 2003, J CLIN INVEST, V112, P527, DOI 10.1172/JCI200318107 | - |
dc.description.citedreference | Petersen KF, 2003, SCIENCE, V300, P1140 | - |
dc.description.citedreference | Rossignol R, 2003, BIOCHEM J, V370, P751, DOI 10.1042/BJ20021594 | - |
dc.description.citedreference | Lee DH, 2003, DIABETOLOGIA, V46, P359, DOI 10.1007/s00125-003-1036-5 | - |
dc.description.citedreference | Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723 | - |
dc.description.citedreference | Poulton J, 2002, HUM MOL GENET, V11, P1581 | - |
dc.description.citedreference | West GB, 2002, P NATL ACAD SCI USA, V99, P2473, DOI 10.1073/pnas.012579799 | - |
dc.description.citedreference | Lee HK, 2001, DIABETES RES CLIN PR, V54, pS57 | - |
dc.description.citedreference | Imbeault P, 2001, INT J OBESITY, V25, P1585, DOI 10.1038/sj.ijo.0801817 | - |
dc.description.citedreference | Mokdad AH, 2001, JAMA-J AM MED ASSOC, V286, P1195, DOI 10.1001/jama.286.10.1195 | - |
dc.description.citedreference | Zhang CY, 2001, CELL, V105, P745 | - |
dc.description.citedreference | Park KS, 2001, AM J PHYSIOL-ENDOC M, V280, pE1007 | - |
dc.description.citedreference | Song J, 2001, DIABETES CARE, V24, P865 | - |
dc.description.citedreference | Park KS, 2001, DIABETES RES CLIN PR, V52, P97 | - |
dc.description.citedreference | Harding JE, 2001, INT J EPIDEMIOL, V30, P15, DOI 10.1093/ije/30.1.15 | - |
dc.description.citedreference | Rasmussen UF, 2001, AM J PHYSIOL-ENDOC M, V280, pE301 | - |
dc.description.citedreference | Lim S, 2000, EUR J APPL PHYSIOL, V82, P407 | - |
dc.description.citedreference | Jucker BM, 2000, P NATL ACAD SCI USA, V97, P6880 | - |
dc.description.citedreference | Lowell BB, 2000, NATURE, V404, P652 | - |
dc.description.citedreference | Weyer C, 2000, J CLIN ENDOCR METAB, V85, P1087 | - |
dc.description.citedreference | Lee HK, 1999, DIABETES RES CLIN PR, V45, P127 | - |
dc.description.citedreference | Hattersley AT, 1999, LANCET, V353, P1789 | - |
dc.description.citedreference | Lee HK, 1998, DIABETES RES CLIN PR, V42, P161 | - |
dc.description.citedreference | Alberti KGMM, 1998, DIABETIC MED, V15, P539 | - |
dc.description.citedreference | Pratley RE, 1998, J CLIN INVEST, V101, P1757 | - |
dc.description.citedreference | Poulton J, 1998, DIABETOLOGIA, V41, P54 | - |
dc.description.citedreference | BUSCEMI S, 1998, INT J OBES S1, V22, pS75 | - |
dc.description.citedreference | Kolpin DW, 1997, J ENVIRON QUAL, V26, P1007 | - |
dc.description.citedreference | Esposti MD, 1996, DIABETES, V45, P1531 | - |
dc.description.citedreference | Solomon KR, 1996, ENVIRON TOXICOL CHEM, V15, P31 | - |
dc.description.citedreference | SCHOTTLER SP, 1994, ENVIRON SCI TECHNOL, V28, P2228 | - |
dc.description.citedreference | KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205 | - |
dc.description.citedreference | HALES CN, 1992, DIABETOLOGIA, V35, P595 | - |
dc.description.citedreference | GRIFFITHS M, 1990, LANCET, V336, P76 | - |
dc.description.citedreference | REAVEN GM, 1988, DIABETES, V37, P1595 | - |
dc.description.citedreference | RAVUSSIN E, 1988, NEW ENGL J MED, V318, P467 | - |
dc.description.citedreference | ROBERTS SB, 1988, NEW ENGL J MED, V318, P461 | - |
dc.description.citedreference | VIRTANEN MJ, 1986, J ENVIRON PATHOL TOX, V7, P73 | - |
dc.description.citedreference | WALLACE DC, 1986, SOMAT CELL MOLEC GEN, V12, P41 | - |
dc.description.citedreference | KNOWLER WC, 1983, AM J PHYS ANTHROPOL, V62, P107 | - |
dc.description.citedreference | LAGUENS R, 1963, EXP MOL PATHOL, V2, P203 | - |
dc.description.citedreference | SMITH RE, 1956, ANN NY ACAD SCI, V62, P403 | - |
dc.description.citedreference | KLEIBER M, 1932, HILGARDIA, V6, P315 | - |
dc.description.tc | 7 | - |
- Appears in Collections:
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.